aod 9604 vs ipamorelin Peptide for Fat Loss: Does It Work? Peptides for Women: A Complete

No changes in IGF-1

Meto's Longevity Panel is designed precisely to characterise the hormonal baseline including IGF-1 that should anchor any such protocol

Practical Takeaways The CJC 1295 and ipamorelin stack remains one of the most evidence backed peptide combinations for restoring healthy growth hormone levels

Key published studies include: Teichman et al., 2006 (JCEM): Dose-dependent GH and IGF-1 elevation with CJC-1295 DAC in healthy adults Raun et al., 1998 (Eur J Endocrinol): Ipamorelin demonstrated selective GH release without cortisol/prolactin elevation Johansen et al., 1999: Phase I/II Ipamorelin trial showed dose-response relationship with no significant adverse effects Bowers et al., 2004: Foundational research on GHRH/GHRP synergistic GH release mechanisms Neither CJC-1295 nor Ipamorelin has completed Phase 3 clinical trials